Topic
6 research guides on 3,5-t2 research.
The deiodinase enzymes - DIO1, DIO2, and DIO3 - decide how much active thyroid hormone reaches tissue, independent of what the thyroid gland produces. This guide explains how the three enzymes work, what impairs them in chronic illness, and why deiodinase dysfunction produces hypothyroid signs with a normal-looking thyroid panel.
The Wilson's T3+T2 enhanced protocol extends Dr. Denis Wilson's original cyclic T3 framework with paired T2 dosing. By supplying T3 for receptor activation and T2 for direct mitochondrial activation simultaneously, the enhanced protocol bypasses both the T4→T3 and T3→T2 conversion bottlenecks. Complete breakdown of the rationale, dose pairings, and how the 1:1 T3+T2 ratio fits into existing Wilson's titration schedules.
The complete 2026 research guide to 3,5-T2 (3,5-diiodo-L-thyronine) - the lesser-known thyroid metabolite that bypasses nuclear receptors and binds directly to mitochondrial cytochrome c oxidase. Mechanism, dose ranges, TSH safety profile, and why it's gaining attention in chronic-illness research.
Wilson's Protocol solved the T4→T3 conversion problem. The body still has to perform a second conversion - T3 to T2 - using the same deiodinase enzymes that the first step depends on. This article explains why the T3 protocol plateau many chronic-illness patients hit is often a T2 production failure, and what that means for next-generation T3+T2 research.
The complete 2026 comparison of T2, T3, and T4 thyroid hormones - hormone structure, receptor affinity, mechanism, half-life, TSH suppression potency, use cases, and why bioenergetic researchers increasingly argue all three are needed for complete metabolic signaling.
The Scorch Protocol is the most-discussed T2-focused research framework in the metabolic-research community. Complete breakdown of the protocol's dose ranges, cycling rationale, lipid-cleansing mechanism, TSH safety profile, and how it compares to other T2 research approaches.